Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model

被引:0
|
作者
Melstrom, Laleh G. [1 ]
Strouch, Matthew [1 ]
Salabat, Mohammad R. [1 ]
Ding, Xian-Zhong [1 ]
Rao, Sambasiva M. [1 ]
Kennedy, Timothy J. [1 ]
Talamonti, Mark S. [1 ]
Bell, Richard H. [1 ]
Adrian, Thomas A. [1 ]
Bentrem, David J. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
D O I
10.1016/j.jamcollsurg.2008.06.245
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:S97 / S97
页数:1
相关论文
共 50 条
  • [41] TOPICAL EFFECTS OF NOVEL INHIBITORS OF 5-LIPOXYGENASE IN AN ANIMAL-MODEL OF EPIDERMAL HYPERPLASIA
    CHAN, CC
    YOUNG, V
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1987, 12 (02) : 154 - 154
  • [42] Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke
    Ye, YN
    Wu, WKK
    Shin, VY
    Bruce, IC
    Wong, BCY
    Cho, CH
    [J]. CARCINOGENESIS, 2005, 26 (04) : 827 - 834
  • [43] EFFECT OF 5-LIPOXYGENASE INHIBITORS ON THE ANTI-IGE-INDUCED CONTRACTION OF PASSIVELY SENSITIZED HUMAN BRONCHUS IN-VITRO
    POATY, V
    RIQUET, M
    LEGALL, G
    FROSSARD, N
    [J]. JOURNAL OF LIPID MEDIATORS, 1993, 8 (02): : 105 - 110
  • [44] In Vitro Cytostatic Effect on Tumor Cells by Carborane-Based Dual Cyclooxygenase-2 and 5-Lipoxygenase Inhibitors
    Braun, Sebastian
    Paskas, Svetlana
    Laube, Markus
    George, Sven
    Hofmann, Bettina
    Loennecke, Peter
    Steinhilber, Dieter
    Pietzsch, Jens
    Mijatovic, Sanja S.
    Maksimovic-Ivanic, Danijela
    Hey-Hawkins, Evamarie
    [J]. ADVANCED THERAPEUTICS, 2023, 6 (04)
  • [45] HYDROXAMIC ACID INHIBITORS OF 5-LIPOXYGENASE .2. POTENT INHIBITORS DESIGNED WITH A SIMPLE BINDING MODEL
    SUMMERS, JB
    MAZDIYASNI, H
    RATAJCZYK, JD
    DYER, RD
    CARTER, GW
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1986, 192 : 20 - MEDI
  • [46] The potential role of products of the 5-lipoxygenase pathway in the prevention of colon cancer with NSAIDs interacting with PPARa
    Shonde, T
    Bennett, A
    Hawkey, C
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A643 - A644
  • [47] The potential of 5-lipoxygenase products in the prevention of colon cancer:: NSAIDs, LTB4, and PPARα
    Shonde, A
    Bennett, AJ
    Hawkey, CJ
    [J]. GUT, 2005, 54 : A30 - A30
  • [48] Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs
    Charlier, C
    Michaux, C
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (7-8) : 645 - 659
  • [49] Discovery of pharmacological agents for triple-negative breast cancer (TNBC): molecular docking and molecular dynamic simulation studies on 5-lipoxygenase (5-LOX) and nuclear factor kappa B (NF-?B)
    Kundu, Sudipto
    Swathi, N.
    Kumar, T. Durai Ananda
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023,
  • [50] Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors
    Ding, Xiaoling
    Zhu, Chen
    Qiang, Hui
    Zhou, Xiaorong
    Zhou, Guoxiong
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2011, 65 (07) : 486 - 490